Apobiologix has an interest in partnering on biosimilar, innovative, and differentiated products to complement its own portfolio/pipeline in the following key therapeutic areas:
Further, we are interested in evaluating the following types of opportunities:
Apobiologix has considerable in-house expertise in formulation development, regulatory affairs, and clinical development, including its own bio-clinical department which is responsible for Phase I-III studies and in-house bioequivalence studies.
Our company has both Commercial and Medical Affairs teams based in Weston, Florida, as well as substantial R&D, clinical development, regulatory affairs and commercial expertise based in Toronto.
For all global opportunities relating to Apobiologix with respect to in-licensing, co-development, distribution, co-promotion, product acquisitions, or other partnership opportunities, please submit your opportunity to:
Global Director, Business Development
200 Barmac Drive
Toronto, ON M9L 2Z7
2400 North Commerce Parkway,
Weston, Florida 33326